| Product Name | NebuSelect™ Recombinant Human Ephrin-A4/EFNA4, His-tag |
|---|---|
| Catalog Number | NBL-242709 |
| Alias/Synonyms | Ephrin-A4/EFNA4; Ephrin-A4; LERK-4; EFNA4; EPLG4; EFL4 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P52798-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242709-100ug | 100ug | Inquire | Inquire | |
| NBL-242709-1mg | 1mg | Inquire | Inquire | |
| NBL-242709-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Ephrin-A4/EFNA4, His-tag
Catalog#:
NBL-242709
Description:
NebuSelect™ Recombinant Human Ephrin-A4/EFNA4, His-tag(Cat#NBL-242709) is expressed in HEK293 with His tag at the C-Terminus.It contains Leu26-Gly171.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 17.5 kDa. Due to glycosylation, the protein migrates to 18-25 kDa based on Bis-Tris PAGE result.
Target Name:
Ephrin-A4/EFNA4; Ephrin-A4; LERK-4; EFNA4; EPLG4; EFL4
Target Information:
Ephrin A4 is one of the ephrin ligand molecules belonging to the tyrosine kinases receptor family. It was originally identified in a T-lymphoma cell line and seen to be expressed in human adult tissue as well as several tumor types. The cytoplasmic pattern of ephrin A4 could identify a subgroup of primary osteosarcoma patients with a high liability for progression, poor prognosis, and inferior response to chemotherapy.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.